Format

Send to

Choose Destination
Int J Tuberc Lung Dis. 2018 Jul 1;22(7):723-730. doi: 10.5588/ijtld.17.0835.

Global tuberculosis targets and milestones set for 2016-2035: definition and rationale.

Author information

1
Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
2
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Abstract

BACKGROUND:

Global tuberculosis (TB) targets were set as part of the World Health Organization's End TB Strategy (2016-2035) and the Sustainable Development Goals (2016-2030).

OBJECTIVE:

To define and explain the rationale for these targets.

DESIGN:

Scenarios for plausible reductions in TB deaths and cases were developed using empirical evidence from best-performing countries and modelling of the scale-up of under-used interventions and hypothetical TB vaccines. Results were discussed at consultations in 2012 and 2013. A final proposal was presented to the World Health Assembly in 2014 and unanimously endorsed by all Member States.

RESULTS:

The 2030 targets are a 90% reduction in TB deaths and 80% reduction in TB incidence compared with 2015 levels. The 2035 targets are for reductions of 95% and 90%, respectively. A third target-that no TB-affected households experience catastrophic costs due to the disease by 2020-was also agreed.

CONCLUSION:

The global TB targets and milestones set for the period 2016-2035 are ambitious. Achieving them requires concerted action on several fronts, but two things are fundamental: 1) progress towards universal health coverage to ensure that everyone with TB can access high-quality treatment; and 2) substantial investment in research and development for new tools to prevent TB disease among the approximately 1.7 billion people infected.

Supplemental Content

Full text links

Icon for Ingenta plc Icon for PubMed Central
Loading ...
Support Center